#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4804304	F	Upregulation of YAP1 protein level in human MM1.S cells at 1 uM measured after 16 hrs by Western blot analysis	Homo sapiens	5	ALA4804281	cell-based format	Patent Bioactivity Data
2.	ALA4804305	F	Downregulation of phosphorylated-MOB1 protein level in human MM1.S cells at 1 to 10 uM measured after 6 hrs by Western blot analysis	Homo sapiens	7	ALA4804281	cell-based format	Patent Bioactivity Data
3.	ALA4804306	B	Inhibition of STK4 (unknown origin) using fluorescein-labelled Ser/Thr-07 peptide as substrate incubated for 1 hr in presence of ATP at Km concentration by Z-LYTE assay	Homo sapiens	59	ALA4804281	single protein format	Patent Bioactivity Data
4.	ALA4804308	B	Inhibition of STK3 (unknown origin) using fluorescein-labelled Ser/Thr-07 peptide as substrate incubated for 1 hr in presence of ATP at Km concentration by Z-LYTE assay	Homo sapiens	11	ALA4804281	single protein format	Patent Bioactivity Data
5.	ALA4804309	B	Inhibition of STK24 (unknown origin) using fluorescein-labelled Ser/Thr-07 peptide as substrate incubated for 1 hr in presence of ATP at Km concentration by Z-LYTE assay	Homo sapiens	12	ALA4804281	single protein format	Patent Bioactivity Data
6.	ALA4804335	B	Inhibition of ABL in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
7.	ALA4804336	B	Inhibition of ARG in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
8.	ALA4804337	B	Inhibition of ACK in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
9.	ALA4804338	B	Inhibition of AKT1 in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
10.	ALA4804339	B	Inhibition of AKT2 in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	3	ALA4804281	cell-based format	Patent Bioactivity Data
11.	ALA4804340	B	Inhibition of AKT3 in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	3	ALA4804281	cell-based format	Patent Bioactivity Data
12.	ALA4804341	B	Inhibition of AMPKa1 in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
13.	ALA4804342	B	Inhibition of AMPKa2 in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
14.	ALA4804343	B	Inhibition of ARAF in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	3	ALA4804281	cell-based format	Patent Bioactivity Data
15.	ALA4804344	B	Inhibition of ATR in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
16.	ALA4804345	B	Inhibition of AURA in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
17.	ALA4804346	B	Inhibition of AURB in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
18.	ALA4804347	B	Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
19.	ALA4804348	B	Inhibition of BARK1 in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data
20.	ALA4804349	B	Inhibition of BRAF in human NCI-H929 cells by mass spectroscopic analysis	Homo sapiens	6	ALA4804281	cell-based format	Patent Bioactivity Data